切换至 "中华医学电子期刊资源库"
高级检索
中华口腔医学研究杂志(电子版)

中华口腔医学研究杂志(电子版) ›› 2015, Vol. 09 ›› Issue (06) : 455 -460. doi: 10.3877/cma.j.issn.1674-1366.2015.06.004

所属专题： 文献；

基础研究

微小RNA-181a抑制唾液腺腺样囊性癌细胞株增殖能力的研究
何倩婷1, 陈丹1, 赵婷婷1, 刘中华1, 王安训1,†()   
  1. 1. 510080　广州，中山大学附属第一医院口腔科
  • 收稿日期:2015-08-28 出版日期:2015-12-01
  • 通信作者: 王安训
  • 基金资助:
    高校基本科研业务费中山大学青年教师重点培育计划(11ykz09); 广东省科技计划国际合作项目(2010B050700015)

The inhibition of miR-181a on proliferation of salivary adenoid cystic carcinoma

Qianting He1, Dan Chen1, Tingting Zhao1, Zhonghua Liu1, Anxun Wang1,†()   

  1. 1. Department of Stomatology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
  • Received:2015-08-28 Published:2015-12-01
  • Corresponding author: Anxun Wang
  • About author:
    Corresponding author: Wang Anxun, Email:
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

何倩婷, 陈丹, 赵婷婷, 刘中华, 王安训. 微小RNA-181a抑制唾液腺腺样囊性癌细胞株增殖能力的研究[J]. 中华口腔医学研究杂志(电子版), 2015, 09(06): 455-460.

Qianting He, Dan Chen, Tingting Zhao, Zhonghua Liu, Anxun Wang. The inhibition of miR-181a on proliferation of salivary adenoid cystic carcinoma[J]. Chinese Journal of Stomatological Research(Electronic Edition), 2015, 09(06): 455-460.

目的

探讨微小RNA（miR）-181a对唾液腺腺样囊性癌（SACC）细胞增殖能力的体内外作用影响。

方法

通过过表达或沉默miR-181a在SACC-LM和SACC-83细胞中的表达。实时荧光定量PCR检测转染后SACC细胞株中miR-181a的表达水平。MTT法检测miR-181a对SACC细胞体外增殖能力的影响。Western blot检测转染后生长因子因子表达的改变。裸鼠皮下移植瘤模型检测miR-181a对SACC细胞体内增殖能力的影响。采用SPSS 17.0软件对数据进行统计学处理，以P<0.05为差异具有统计学意义。

结果

实时荧光定量PCR结果示，转染后SACC-LM细胞中miR-181a表达升高（t = -9.198，P = 0.012），而SACC-83细胞中miR-181a表达降低（t = -7.241，P = 0.019）；SACC-LM细胞增殖能力降低（t = -4.58，P = 0.045），而SACC-83细胞增殖能力提高（t = 3.016，P = 0.03）；SACC-LM细胞中转化生长因子β2（TGF-β2）、神经生长因子（NGF）和血管内皮生长因子（VEGF）的表达水平均下调，而SACC-83细胞中TGF-β2、NGF和VEGF的表达水平均升高。裸鼠皮下移植瘤模型结果显示，miR-181a mimics组移植瘤瘤体明显小于mimics NC组（t = -4.692，P = 0.043）。

结论

miR-181a能抑制SACC细胞体内体外的增殖能力。

关键词: 微小RNA-181a, 涎腺, 癌，腺样囊性, 增殖, 体外, 体内
Objective

To investigate the effect of microRNA (miR) -181a in proliferation of salivary adenoid cystic carcinoma (SACC) in vitro and in vivo.

Methods

The SACC cell lines SACC-LM and SACC-83 were transfected with miR-181a mimics and miR-181a LNA respectively. QRT-PCR analysis was used to detect the expression of miR-181a in the paired SACC cell lines after transfection. MTT assay was performed to analyze the effect of miR-181a on proliferation after transfection. Western blot analysis was used to demonstrate the proliferation related genes after transfection. Tumorigenesis model in nude mice was performed to analyze the effect of miR-181a on proliferation of SACC cell lines after transfection in vivo. Data were analyzed using the Statistical Package for the Social Science (SPSS) , Version 17.0. For all statistical analyses, P<0.05 was considered statistically significant.

Results

Ectopic transfection of the miR-181a mimics to the SACC-LM cells led to increased miR-181a expression (t = -9.198, P = 0.012) while the miR-181a expression was decreased in SACC-83 cells treated with miR-181a LNA (t = -7.241, P = 0.019) . After transfection, the proliferation rate of SACC-LM cells was reduced (t = -4.58, P = 0.045) , while it was increased in SACC-83 cells (t = 3.016, P = 0.03) . Gene expression of TGF-β2, NGF and VEGF was decreased in SACC-LM cells after transfection, while increased in transfected SACC-83 cells. Ectopic transfection of the miR-181a mimics to the SACC-LM cells led to decrease in tumorigenesis ability (t = -4.692, P = 0.043) .

Conclusion

MiR-181a can suppress the proliferation of SACC in vitro and in vivo.

Key words: MicroRNA-181a, Salivary glands, Carcinoma, adenoid cystic, Proliferation, In vitro, In vivo
表1 miR-181a的引物序列
mircroRNA 引物 引物序列
Hsa-miR-181a HmiR-181a-RT GTCGGGTCCAGAGCAGGGTCCGAGGTA
? ? CACGTTCGCTCTGGACCCGACACTCAC
? HmiR-181a-FO-1 TGCCGAACATTCAACGCT
? HmiR-RE-4 AGAGCAGGGTCCGAGGTA
U6snRNA U6snRNA FO ATTGGAACGATACAGAGAAGATT
? U6snRNA RE GGAACGCTTCACGAATTTG
图1 miR-181a mimics/LNA转染后SACC细胞中miR-181a的表达
图2 miR-181a mimics/LNA转染后对SACC细胞增殖能力的影响
图3 miR-181a mimics/LNA转染后对SACC细胞中生长因子表达的影响
图4 过表达miR-181a对SACC-LM细胞体内成瘤能力的影响
[1]
Thompson L. World Health Organization classification of tumours：pathology and genetics of head and neck tumours[J]. Ear Nose Throat J，2006，85(2):74.
[2]
Mishra SK，Siddique HR，Saleem M. S100A4 calcium-binding protein is key player in tumor progression and metastasis：preclinical and clinical evidence[J]. Cancer Metastasis Rev，2012，31(1-2):163-172.
[3]
Ru Y，Dancik GM，Theodorescu D. Biomarkers for prognosis and treatment selection in advanced bladder cancer patients[J]. Curr Opin Urol，2011，21(5):420-427.
[4]
Kim VN，Nam JW. Genomics of microRNA[J]. Trends Genet，2006，22(3):165-173.
[5]
Baranwal S，Alahari SK. miRNA control of tumor cell invasion and metastasis[J]. Int J Cancer，2010，126(6):1283-1290.
[6]
Ciafrè SA，Galardi S，Mangiola A，et al. Extensive modulation of a set of microRNAs in primary glioblastoma[J]. Biochem Biophys Res Commun，2005，334(4):1351-1358.
[7]
Shin KH，Bae SD，Hong HS，et al. miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras[J]. Biochem Biophys Res Commun，2011，404(4):896-902.
[8]
何倩婷，刘中华，招洛丹，等. miR-181a抑制唾液腺腺样囊性癌侵袭、转移机制的实验研究[J]. 中国口腔颌面外科杂志，2015，13(1):11-15.
[9]
Ikushima H，Miyazono K. TGFbeta signalling：a complex web in cancer progression[J]. Nat Rev Cancer，2010，10(6):415-424.
[10]
Siegel PM，Massagué J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer[J]. Nat Rev Cancer，2003，3(11):807-821.
[11]
Tang B，Vu M，Booker T，et al. TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression[J]. J Clin Invest，2003，112(7):1116-1124.
[12]
Sortino MA，Condorelli F，Vancheri C，et al. Mitogenic effect of nerve growth factor（NGF）in LNCaP prostate adenocarcinoma cells：role of the high- and low-affinity NGF receptors[J]. Mol Endocrinol，2000，14(1):124-136.
[13]
Zhu Z，kleeff J，Kayed H，et al. Nerve growth factor and enhancement of proliferation，invasion，and tumorigenicity of pancreatic cancer cells[J]. Mol Carcinog，2002，35(3):138-147.
[14]
Kishibe K，Yamada Y，Ogawa K. Production of nerve growth factor by mouse hepatocellular carcinoma cells and expression of TrkA in tumor-associated arteries in mice[J]. Gastroenterology，2002，122(7):1978-1986.
[15]
Witte L，Hicklin DJ，Zhu Z，et al. Monoclonal antibodies targeting the VEGF receptor-2（Flk1/KDR）as an anti-angiogenic therapeutic strategy[J]. Cancer Metastasis Rev，1998，17(2):155-161.
[16]
Gerwins P，Sköldenberg E，Claesson-Welsh L. Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis[J]. Crit Rev Oncol Hematol，2000，34(3):185-194.
[1] 蒋佳纯, 王晓冰, 陈培荣, 许世豪. 血清学指标联合常规超声及超声造影评分诊断原发性干燥综合征的临床价值[J]. 中华医学超声杂志（电子版）, 2023, 20(06): 622-630.
[2] 贾春岩, 李月河. 涎腺腺泡细胞癌的超声表现及病理对照分析[J]. 中华医学超声杂志（电子版）, 2023, 20(04): 462-466.
[3] 吴俊贤, 曾俊杰, 许有银, 苑博. 体外冲击波疗法辅助治疗肩袖修补术后关节僵硬[J]. 中华关节外科杂志(电子版), 2023, 17(04): 571-576.
[4] 王玲燕, 邹磊, 洪亮, 宋三兵, 付润, 熊胜男, 宋晓春. 心脏外科术后患者并发低三碘甲状腺原氨酸综合征的影响因素分析[J]. 中华危重症医学杂志(电子版), 2023, 16(05): 399-402.
[5] 顾娟, 孙擎擎, 胡方方, 曹义娟, 祁玉娟. 子宫内膜容受性检测改善胚胎反复种植失败患者妊娠结局的临床应用[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 582-587.
[6] 江振剑, 蒋明, 黄大莉. TK1、Ki67蛋白在分化型甲状腺癌组织中的表达及预后价值研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 623-626.
[7] 徐慧新, 刘波, 唐立钧. 体外冲击波治疗>1 cm输尿管上段结石失败的预测模型建立[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 506-511.
[8] 李国良, 吴凡, 李浩民, 江俊斌, 郭泽雄, 卓育敏, 马鑫, 赖彩永. 抽栓技术在完全腹腔镜左肾癌合并Ⅳ级腔静脉癌栓取出术的应用[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 403-406.
[9] 中国医师协会妇产科医师分会妇科单孔腹腔镜全国科研协作组. 妇科单孔腹腔镜手术镜下联合体外操作模式临床应用专家共识[J]. 中华腔镜外科杂志(电子版), 2023, 16(04): 200-209.
[10] 徐红莉, 杨钰琳, 薛清, 张茜, 马丽虹, 邱振刚. 体外冲击波治疗非特异性腰痛疗效的系统评价和Meta分析[J]. 中华老年骨科与康复电子杂志, 2023, 09(05): 307-314.
[11] 廖家权, 吴波, 唐昌敏. 体外冲击波联合肌电生物反馈对脑卒中后足下垂的影响[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(05): 286-292.
[12] 邓世栋, 刘凌志, 郭大勇, 王超, 黄忠欣, 张晖辉. 沉默SNHG1基因对膀胱癌细胞增殖、凋亡、迁移和铁死亡的影响[J]. 中华临床医师杂志(电子版), 2023, 17(07): 804-811.
[13] 方辉, 李菲, 张帆, 魏强, 陈强谱. 外源性瘦素对梗阻性黄疸大鼠肠黏膜增殖的影响[J]. 中华临床医师杂志(电子版), 2023, 17(05): 575-580.
[14] 沈袁恒. 医学检验实验室自建检测方法的现状分析与管理展望[J]. 中华临床实验室管理电子杂志, 2023, 11(04): 200-206.
[15] 高明生, 张盼盼, 包楠迪, 孟繁森, 李婷婷, 徐世平. 一种新型乳链菌素混合物体外杀灭幽门螺杆菌的实验研究[J]. 中华胃肠内镜电子杂志, 2023, 10(04): 258-263.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号